These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7518354)

  • 1. The CSF myelin basic protein in pediatric hydrocephalus.
    Longatti PL; Guida F; Agostini S; Carniato B; Carteri A
    Childs Nerv Syst; 1994 Mar; 10(2):96-8. PubMed ID: 7518354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CSF myelin basic protein: a reliable marker of actual cerebral damage in hydrocephalus.
    Longatti PL; Canova G; Guida F; Carniato A; Moro M; Carteri A
    J Neurosurg Sci; 1993 Jun; 37(2):87-90. PubMed ID: 7507986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid myelin basic protein in hydrocephalus.
    Sutton LN; Wood JH; Brooks BR; Barrer SJ; Kline M; Cohen SR
    J Neurosurg; 1983 Sep; 59(3):467-70. PubMed ID: 6193255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid myelin basic protein immunoreactivity as an indicator of brain damage in children.
    Levin SD; Hoyle NR; Brown JK; Thomas DG
    Dev Med Child Neurol; 1985 Dec; 27(6):807-13. PubMed ID: 2419189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators of hypoxia in cerebrospinal fluid of hydrocephalic children with suspected shunt malfunction.
    Castro-Gago M; Rodríguez-Segade S; Camiña F; Bollar A; Rodríguez-Núñez A
    Childs Nerv Syst; 1993 Aug; 9(5):275-7. PubMed ID: 8252517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers of neuroinflammation in children with hydrocephalus and shunt malfunction.
    Harris CA; Morales DM; Arshad R; McAllister JP; Limbrick DD
    Fluids Barriers CNS; 2021 Jan; 18(1):4. PubMed ID: 33514409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The necessity of shunt series.
    Vassilyadi M; Tataryn ZL; Alkherayf F; Udjus K; Ventureyra EC
    J Neurosurg Pediatr; 2010 Nov; 6(5):468-73. PubMed ID: 21039171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the cerebrospinal fluid protein concentration increase the risk of shunt complications?
    Brydon HL; Hayward R; Harkness W; Bayston R
    Br J Neurosurg; 1996 Jun; 10(3):267-73. PubMed ID: 8799537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergency in children with implanted cerebrospinal fluid shunt].
    Orlov IuA; Borisova IA; Protsenko IP; Plavskiĭ NV; Al-Assali A
    Klin Khir (1962); 1993; (7-8):45-8. PubMed ID: 8139194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
    Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
    Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical properties of cerebrospinal fluid of relevance to shunt function. 1: The effect of protein upon CSF viscosity.
    Brydon HL; Hayward R; Harkness W; Bayston R
    Br J Neurosurg; 1995; 9(5):639-44. PubMed ID: 8561936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 2: Management of posthemorrhagic hydrocephalus in premature infants.
    Mazzola CA; Choudhri AF; Auguste KI; Limbrick DD; Rogido M; Mitchell L; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():8-23. PubMed ID: 25988778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus.
    Fulkerson DH; Vachhrajani S; Bohnstedt BN; Patel NB; Patel AJ; Fox BD; Jea A; Boaz JC
    J Neurosurg Pediatr; 2011 Feb; 7(2):147-51. PubMed ID: 21284459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement.
    West GA; Berger MS; Geyer JR
    Pediatr Neurosurg; 1994; 21(4):254-8; discussion 259. PubMed ID: 7865412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a better understanding of the cellular basis for cerebrospinal fluid shunt obstruction: report on the construction of a bank of explanted hydrocephalus devices.
    Hanak BW; Ross EF; Harris CA; Browd SR; Shain W
    J Neurosurg Pediatr; 2016 Aug; 18(2):213-23. PubMed ID: 27035548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experiences with the Orbis-Sigma-System as a ventriculo-peritoneal shunt.
    Kaiser G; Bittel M
    Eur J Pediatr Surg; 1992 Jun; 2(3):186-7. PubMed ID: 1498115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience.
    Piatt JH; Carlson CV
    Pediatr Neurosurg; 1993; 19(5):233-41; discussion 242. PubMed ID: 8398847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
    Willis BK; Kumar CR; Wylen EL; Nanda A
    Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus.
    Nishiyama K; Mori H; Tanaka R
    J Neurosurg; 2003 May; 98(5):1027-31. PubMed ID: 12744362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.